assembly Bill A133

2021-2022 Legislative Session

Relates to creating a wholesale prescription drug importation program

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (2)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jan 05, 2022 referred to higher education
Jan 06, 2021 referred to higher education

Co-Sponsors

view additional co-sponsors

Multi-Sponsors

A133 (ACTIVE) - Details

See Senate Version of this Bill:
S1737
Current Committee:
Assembly Higher Education
Law Section:
Public Health Law
Laws Affected:
Add Art 2-A Title 2 §280-d, Pub Health L
Versions Introduced in 2019-2020 Legislative Session:
A7588, S5682

A133 (ACTIVE) - Summary

Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.

A133 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    133
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                (PREFILED)
 
                              January 6, 2021
                                ___________
 
 Introduced by M. of A. GOTTFRIED, BARRON, CAHILL, COOK, DINOWITZ, ENGLE-
   BRIGHT,  GALEF, GUNTHER, HUNTER, LAVINE, MAGNARELLI, MONTESANO, RAMOS,
   J. RIVERA,  L. ROSENTHAL,  SEAWRIGHT,  SIMON,   ZEBROWSKI,   JACOBSON,
   STIRPE,  HEVESI,  CARROLL,  MIKULIN,  REYES, BENEDETTO, CRUZ, EPSTEIN,
   COLTON, NIOU -- Multi-Sponsored by -- M. of A.  BUTTENSCHON,  LUPARDO,
   THIELE -- read once and referred to the Committee on Higher Education
 
 AN  ACT to amend the public health law, in relation to creating a whole-
   sale prescription drug importation program
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Title 2 of article 2-A of the public health law is amended
 by adding a new section 280-d to read as follows:
   § 280-D. WHOLESALE PRESCRIPTION DRUG  IMPORTATION  PROGRAM.    1.  (A)
 THERE  IS HEREBY CREATED IN THE DEPARTMENT A WHOLESALE PRESCRIPTION DRUG
 IMPORTATION PROGRAM.
   (B) AS USED IN THIS  SECTION,  UNLESS  THE  CONTEXT  CLEARLY  REQUIRES
 OTHERWISE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS:
   (I)  "WHOLESALE  PRESCRIPTION  DRUG  IMPORTATION PROGRAM" OR "PROGRAM"
 MEANS THE WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM CREATED  UNDER
 THIS SECTION.
   (II)  "PRESCRIPTION  DRUG  WHOLESALER"  MEANS  AN ENTITY AUTHORIZED TO
 ACQUIRE PRESCRIPTION DRUGS AND SELL OR DISTRIBUTE THEM WHOLESALE IN  THE
 STATE.
   (III)  "APPROVED  WHOLESALER"  MEANS  A  PRESCRIPTION  DRUG WHOLESALER
 APPROVED UNDER THIS SECTION TO PARTICIPATE IN THE PROGRAM.
   (C) THE COMMISSIONER  SHALL  DEVELOP  AND  IMPLEMENT  THE  PROGRAM  IN
 CONSULTATION  WITH INTERESTED STAKEHOLDERS AND APPROPRIATE FEDERAL OFFI-
 CIALS. THE PROGRAM SHALL COMPLY WITH  APPLICABLE  FEDERAL  REQUIREMENTS,
 INCLUDING  21  U.S.C.  § 384, AND REQUIREMENTS REGARDING SAFETY AND COST
 SAVINGS. UNDER THE PROGRAM:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets